Quarterly report · Q2
3391.TEDINET S100PW9M
Period2022-05-16 → 2022-11-15
Filed2022-12-28
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥484.1bn | 2022-05-16 → 2022-11-15 | Cons. | Net sales |
| Revenue | ¥915.7bn | 2021-05-16 → 2022-05-15 | Cons. | Net sales (5-year summary) |
| Revenue | ¥462.5bn | 2021-05-16 → 2021-11-15 | Cons. | Net sales |
| Operating income | ¥24.7bn | 2022-05-16 → 2022-11-15 | Cons. | Operating income |
| Operating income | ¥22.7bn | 2021-05-16 → 2021-11-15 | Cons. | Operating income |
| Ordinary income | ¥24.8bn | 2022-05-16 → 2022-11-15 | Cons. | Ordinary income |
| Ordinary income | ¥40.1bn | 2021-05-16 → 2022-05-15 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥22.6bn | 2021-05-16 → 2021-11-15 | Cons. | Ordinary income |
| Profit before tax | ¥25.5bn | 2022-05-16 → 2022-11-15 | Cons. | Income before income taxes |
| Profit before tax | ¥22.5bn | 2021-05-16 → 2021-11-15 | Cons. | Income before income taxes |
| Net income (owners) | ¥14.6bn | 2022-05-16 → 2022-11-15 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥21.4bn | 2021-05-16 → 2022-05-15 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥12.7bn | 2021-05-16 → 2021-11-15 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥16.6bn | 2022-05-16 → 2022-11-15 | Cons. | Profit loss |
| Net income | ¥14.3bn | 2021-05-16 → 2021-11-15 | Cons. | Profit loss |
| Total assets | ¥530.9bn | at 2022-11-15 | Cons. | Assets |
| Total assets | ¥562.4bn | at 2022-05-15 | Cons. | Assets |
| Total assets | ¥489.0bn | at 2021-11-15 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥231.2bn | at 2022-11-15 | Cons. | Liabilities |
| Total liabilities | ¥278.3bn | at 2022-05-15 | Cons. | Liabilities |
| Net assets / equity | ¥299.7bn | at 2022-11-15 | Cons. | Net assets |
| Net assets / equity | ¥284.0bn | at 2022-05-15 | Cons. | Net assets |
| Net assets / equity | ¥287.1bn | at 2021-11-15 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥82.3bn | at 2022-11-15 | Cons. | Cash and deposits |
| Cash and deposits | ¥127.0bn | at 2022-05-15 | Cons. | Cash and deposits |
| Cash & equivalents | ¥82.2bn | at 2022-11-15 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥126.9bn | at 2022-05-15 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥67.3bn | at 2021-11-15 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥116.4bn | at 2021-05-15d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥19.7bn | 2022-05-16 → 2022-11-15 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥35.8bn | 2021-05-16 → 2022-05-15 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥26.5bn | 2021-05-16 → 2021-11-15 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥16.3bn | 2022-05-16 → 2022-11-15 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥28.4bn | 2021-05-16 → 2022-05-15 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.1bn | 2021-05-16 → 2021-11-15 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥8.7bn | 2022-05-16 → 2022-11-15 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥3.1bn | 2021-05-16 → 2022-05-15 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥8.6bn | 2021-05-16 → 2021-11-15 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥301.27 | 2022-05-16 → 2022-11-15 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥146.79 | 2022-08-16 → 2022-11-15d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥440.59 | 2021-05-16 → 2022-05-15 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥262.46 | 2021-05-16 → 2021-11-15 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥107.19 | 2021-08-16 → 2021-11-15d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥300.4 | 2022-05-16 → 2022-11-15 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥439.19 | 2021-05-16 → 2022-05-15 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥261.62 | 2021-05-16 → 2021-11-15 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 51.4% | at 2022-11-15 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.9% | at 2022-05-15 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.6% | at 2021-11-15 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 510
| Item | Context | Value | Unit |
|---|---|---|---|
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Description of fact that companys business comprises single segment | CurrentYTDDuration | Original text (Japanese)当社グループは、医薬品・化粧品等を中心とした物販事業の単一セグメントであるため、記載を省略しております。 | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |